Abstract: A flavor composition for an oral electrolyte hydrate solution comprises ethyl esters, citrus oil concentrates, and sweet and fruity flavor components. Ethyl esters are used instead of more typical allyl esters because they are innocuous in dehydrated children whose health may be compromised. The ethyl esters are selected from ethyl acetate, ethyl butyrate, ethyl caproate, ethyl 2-methylbutyrate and ethyl heptanoate. The flavor composition provides an innocuous tutti-frutti (bubble gum) flavor to the oral electrolyte hydrate solution.

Abstract: A method is disclosed for improving the stability of Vitamin D in liquid nutritional products which contain hydrolyzed protein or free amino acids as nitrogen sources. Vitamin C is added before or after a preliminary heat treatment of the liquid nutritional product and at a concentration exceeding 300 mg/l, such that the initial concentration of Vitamin C is at least 300 mg/l during the shelf-life of the liquid nutritional product. An emulsifier is added to the liquid nutritional product prior to preliminary heat treatment, the emulsifier being a diacetyltartaric acid ester of monoglycerides and diglycerides. Cystine is added following the preliminary heat treatment.

Abstract: The present invention relates to a method for the treatment and prevention of diarrhea comprising administering to humans a sugar selected from the group consisting of a caramel composition comprising a high content of fructose oligosaccharides, termed sucrose thermal oligosaccharides (STO), a composition comprising sucrose thermal kestoses, and fructoglucan polymers. The sugars are a natural product and greatly speed recovery from diarrhea and reduce the recurrence of diarrhea.

Abstract: The present invention provides formulated milk compositions for infants analogous to human milk in which non-protein nitrogen components are abundant and the contents of .beta.-lactoglobulin and/or .alpha..sub.S casein are reduced.

Abstract: A novel therapeutical use of L-carnitine, acyl L-carnitines and the pharmacologically acceptable salts thereof is disclosed for the treatment of non-insulin-dependent patients with a view to enhancing their peripheral glucose utilization.

Abstract: A nutritious milk composition containing a specific ratio of raw soybean milk to raw cows' milk which is an effective milk product for the regulation of micronutrients, e.g., methionine and calcium contents and for the production of a synergistic effect between saturated and unsaturated fatty acids.

Abstract: Food products for nutrition of infants which contain no more than subirritant amounts of free long-chain (C.sub.16 -C.sub.22) fatty acids and triglycerides thereof are disclosed. Providing esters, such as ethyl esters, of such fatty acids in infant food products essentially eliminates the tendency of the fatty acid to damage the infant intestinal epithelium, but permits absorption and processing of the fatty acid moiety.

Abstract: Disclosed is a milk protein partial hydrolysate prepared by enzymatic hydrolysis and infant formula prepared therefrom. The hydrolysate has reduced antigenicity and is prepared from a mixture of whey protein and casein wherein the degree of hydrolysis is between 4 and 10%.

Abstract: Infant formula and baby food compositions are presented which contain single cell edible oil which is recovered from dinoflagellates and which lacks unpleasant tastes and fishy odors. This single cell edible oil comprises at least 70% triglycerides which contain about 20-35% docosahexaenoic acid (DHA) and lack eicosapentaenoic acid (EPA). To produce the single cell oil, the dinoflagellates are cultivated in fermentors and induced to produce the single cell oil which is subsequently recovered by extraction with solvents.

Abstract: A method for improving the stability of Vitamin D in liquid nutritional products which contain hydrolyzed protein or free amino acids as a nitrogen source. Vitamin C is added to a liquid nutritional product at a concentration exceeding 300 mg/l, such that the concentration of Vitamin C is at least 300 mg/l during the shelf-life of the liquid nutritional product. Preferably the addition of Vitamin C occurs after the completion of preliminary heat treating of the liquid nutritional product. Alternatively, the addition of Vitamin C occurs prior to the preliminary heat treating of the liquid nutritional product. Preferably, an emulsifier is added to the liquid nutritional product prior to preliminary heat treating, with the emulsifier being a diacetyltartaric acid ester of monoglycerides and diglycerides; and cystine is added following the completion of preliminary heat treating.

Abstract: The present invention provides a method for preparing and storing biological samples prior to measuring ionized Mg.sup.2+ concentrations in order to obtain accurate and reproducible readings. A novel method for accurately reading ionized magnesium ion concentrations in biological samples is provided. A method for monitoring ionized Mg.sup.2+ concentrations and ionized Ca.sup.2+ :Mg.sup.2+ ratios in a patient, useful in diagnosing and prognosing disease states including cardiopulmonary bypass surgery, hypertension, abnormal pregnancy, head trauma, and fetal abnormalities is provided as well as a composition and a method of treating a patient with ionized Mg.sup.2+ or ionized Ca.sup.2+ and Mg.sup.2+.

Abstract: A hypercaloric formula providing nutritional support for human infants having chronic lung disease, said formula having a caloric density of at least 800 kcalories per liter of formula and wherein not less than 56% of the total calories in said formula is derived from fat; not more than 15% of total calories is derived from a high quality protein source; and from about 20-27% of total calories is from a carbohydrate source; said formula having a calcium to phosphorous ratio in the range of 1.4 to 2.2, and having an m-inositol concentration of at least 50 milligrams per liter of formula.

Abstract: Novel liquid nutritional compositions comprising a lipid fraction, a protein fraction and a specific combination of glucides useful as dietetics and therapeutics.

Abstract: The present invention relates to a process for manufacturing a composition containing sialic acids. The process of the present invention comprises the steps of: (a) adjusting cheese whey or rennet whey to a pH of 2-5; (b) contacting the whey with a cation exchanger, to produce an exchanger-passed solution; (c) adjusting the pH of the exchanger-passed solution to a pH of 4 or lower; and then (d) concentrating and/or desalting the exchanger-passed solution. According to the present invention, it is possible to produce a composition having a high sialic acids content at a low cost and in a simple and easy manner on an industrial scale. The high sialic acids content composition thus produced can be utilized as food materials or medical materials and therefore is very useful, industrially.

Abstract: A powdered nutritional product has an oil blend which contains soy oil and/or marine oil. In order to minimize oxidation of the product an antioxidant system of natural ingredients is incorporated therein. The antioxidant system is made up of ascorbyl palmitate, beta carotene and/or mixed tocopherols, and citrate.

Abstract: In a guar-flour-containing drink and tube food by adding sodium alginate and/or agar-agar a stabilizing is achieved and the precipitation of the hydrocolloid guar flour during storage prevented.

Abstract: A liquid nutritional product for enteral feeding contains a fat source which provides desirable effects when fed to pulmonary patients. The fat source having by weight a ratio of [n-(6) to n-(3)] fatty acids from the group consisting of Linoleic acid (18:2n6), Gamma-Linolenic acid (18:3n6), and Arachidonic acid (20:4n6) to fatty acids from the group consisting of Alpha-Linolenic acid (18:3n3), Stearidonic acid (18:4n3), Eicosapentaenoic acid (20:5n3), Docosapentaenoic acid (22:5n3) and Docosahexaenoic acid (22:6n3) in the range of about 1.5 to about 3.0, a ratio of Linoleic acid (18:2n6) to Alpha-Linolenic acid (18:3n3) in the range of about 3.0 to about 10.0, and a ratio of the sum of Eicosapentaenoic acid (20:5n3) and Docosahexaenoic acid (22:6n3) to Gamma-Linolenic acid (18:3n6) in the range of about 1.0 to about 10.0. In a preferred embodiment the nutritional product contains quantities of nutrients having anti-oxidant properties in vivo, such as beta-carotene, vitamin E, vitamin C, selenium, and taurine.

Abstract: A liquid nutritional product for trauma and surgery patients has a caloric density of about 1.2 to 1.5 Kcal/mL and a calorie to nitrogen ratio of about 112:1 to 145:1. A portion of the protein system comprises partially digested protein, and supplemental L-arginine provides about 1-3% of the total calories in the product. The lipid system has a ratio of linoleic acid to alpha linoleic acid in the range of about 3.5:1 to about 5.5:1.

Abstract: A variety of different food products, prepared from edible tubers of the morning glory family, Convolvulaceae. are substitutes for wheat and other grains, milk, eggs, and a partial substitute for nuts.

Abstract: A hypoallergenic milk which has the flavor and smell of natural whole mammalian milk. The hypoallergenic milk is formed by combining a mixture of mineral salts approximately the mineral content of milk, carbohydrate and hypoallergenic protein. Hypoallergenic fat, vitamins and other components are optionally added to meet the minimum daily nutritional requirements for milk. The ingredients are ultrafiltered either separately or in combination as needed to remove allergenic molecules.

Abstract: A high potency dietary composition for treating patients suffering from malnutrition and other related disorders. The dietary compositions comprise sufficient protein, fat, carbohydrate, vitamins, minerals and trace elements to meet the nutritional requirements of the patient, wherein the protein ingredient is derived from amaranth. The amaranth content and proportions of other nutrients of the compositions can be varied, depending on the particular condition to be treated, to provide better patient tolerance and a lower incidence of side effects. The amaranth-containing dietary compositions are suitable for use by low birthrate infants, malnourished children suffering from a nutrient deficiency, as well as by adult patients having a chronic illness.

Abstract: The present invention is directed to the modification of bovine milk to simulate human milk protein composition which can be used in infant formulas. This is accomplished by low temperature ultrafiltration or microfiltration of bovine milk which has been pretreated at about 4.degree. C. for 4 or more hours for micellar dissociation of .beta.-casein, using either a 100,000 molecular weight (M.W.) cut-off or 0.1 .mu.M to 0.2 .mu.M membranes; permeates are obtained in which the .DELTA..sub.s -caseins are eliminated or substantially reduced; and preferably the .beta.-lactoglobulin is reduced to levels of 4% or less through pH adjustment and sodium chloride addition.

Abstract: There is disclosed a hypoallergenic (oligoantigenic) nutritional formula comprising a homogeneous powder of such fineness that it will form a water suspension resembling milk which will have acceptable stability, will keep fresh in a refrigerator after allementation for approximately 24 hours and will not block a standard feeding teat, comprising meat selected for its low allergenicity as the sole or substantially the sole source of protein content together with lipid and carbohydrate additives, and a vitamin and mineral content, all in such proportions as will constitute a nutritionally balanced food which may be regarded as hypoallergenic and/or oligoantigenic.

Abstract: Dietetic nutrient compositions suitable for consumption by patients with kidney insufficiency comprise proteins, fats, carbohydrates, and mineral substances in a manner resembling cow's milk as regards the sensory aspects and the processability. The compositions have a high total energy content, are albumin-poor and phosphorus-poor and have a high calcium content. The compositions have good taste properties and are suitable for sustained treatment of patients with chronic kidney insufficiency. The compositions can be processed in the context of numerous lactovegetable recipes.

Abstract: Nucleosides and/or nucleotides are added to non-milk based infant formulas, to provide a formula having enhanced physiological properties and also closely resemble human milk. Additionally, nutritionally balanced diet formulations are described having nucleosides and/or nucleotides incorporated therein.

Abstract: A hypoallergenic milk which has the flavor and smell of natural whole mammalian milk is disclosed herein. The hypoallergenic milk is made from the ultrafiltered permeate of cow's milk, whey, or other milk fraction. The permeate is substantially free of cow's milk protein and fat. The permeate is supplemented with hypoallergenic protein, and optionally fat, vitamins and minerals to meet the minimum daily nutritional requirements for milk.

Abstract: Method for producing a proteolytic complex formed after cultivation of a strain of Streptomyces fradiae while maintaining the pH of the culture medium between 7 and 7.5, and extracting said complex by filtration in the presence of a clarifying agent and ultrafiltration on a specific membrane and finally atomization; the invention also relates to the new proteolytic complex thus obtained and its applications in zootechny due to its stimulating effect on the activity of the pancreas.

Abstract: A novel liquid nutritional for use as an infant formula for use in the treatment of infantile colic is disclosed. The formula comprises protein, fat, carbohydrates and dietary fiber of a concentration of between 3.1 and 14.1 grams of fiber per liter of formula. Specific preferred protein, fat, carbohydrate and fiber sources are disclosed. Also disclosed is a method of treating infants with colic by feeding an infant the formula made in accordance with the invention. Also disclosed is a method for manufacturing the infant formula of the invention.

Abstract: An infant food formulation substantially approximating human milk in fatty acid composition comprising a mixture of DHA and EPA in a ratio of approximately 3:2 by weight, immunoglobulins to mimic the immunoglobulin content of mother's milk, a source of protein, a source of carbohydrate, a source of ash, and sufficient water to provide an easily assimilable infant formula, the DHA, the EPA, and the immunoglobulins being encapsulated in capsules having a diameter of less than 350.mu..

Abstract: Disclosed herein are all vegetable oil fat compositions having a randomized palmitic acid oil as the sole palmitic acid oil. The novel all vegetable oil fat compositions are particularly for use in human infant nutritional products and combine a lauric acid oil, an oleic acid oil and a linoleic acid oil with the randomized palmitic acid oil. Sunflower oleic oil and canola (LEAR) oil may be used as oleic acids oils. For preterm or low birth weight infants, medium-chain triglycerides (MCTs) are also included in the all vegetable oil fat compositions of the invention.

Abstract: A device for mounting thereon a consumable confection. The invention is a combination of a mouth and lip conforming confection that is mounted on a drip-catching, stylistically shaped, biodegradable handle that can be grasped comfortably and securely by a toddler. The drip catch device may be either of a consumable composition and secured to the handle by a nontoxic, consumable musilage, or it may be formed integrally with the handle and be of a nontoxic, disposable, biodegradable composition. The main objective of the invention is to provide a confection holder, whether for frozen product or other solid or semi-solid product, that may be securely grasped by a toddler and which has the shape most comfortably and easily received into the toddler's mouth. The base handle is biodegradable and is disposable; it provides an aseptic means for the toddler to handle the confection during its consumption.

Abstract: This invention concerns a process for preparing soluble rice protein concentrate with reduced levels of manganese, aluminum, selenium and phytic acid and improved digestibility from rice raw material comprising:digesting the raw material reduced in particle size to permit efficient enzyme action in an aqueous medium with an alpha-amylase enzyme at an operable pH and temperature for a period of time sufficient to solubilize a substantial portion of the rice starch and form a liquid slurry;heating the rice starch slurry at 105.degree. C. to 130.degree. C. for 30 to 60 seconds;separating the high protein rice flour from the rice syrup;treating a slurry of the high protein rice flour with a protease enzyme at an operable pH and temperature in an amount and for a period of time to solubilize the rice protein:clarifying the protease treated slurry to provide a soluble rice protein concentrate with reduced manganese, aluminum, selenium and phytic acid and improved digestibility.

Abstract: New strains of Lactobacillus capable of adhering to the gut epithelial cells of various species of animals and useful as dietary supplements.

Abstract: Disclosed is milk lactoferrin as a dietary ingredient which promotes growth of the gastrointestinal tract of human infants and newborn nonhuman animals immediately on birth when added to an infant formula or given separately as a dietary supplement thus reducing chronic diarrhea, assisting in the management of short gut syndrome, and avoiding, at least to some extent, chronic intractable diarrhea of the infant.

Abstract: Active ingredients useful in chewable articles of commerce are physically encased in non-porous, chewable, particles of elastomer and such particles are then incorporated in the articles of commerce. During mastication of the chewable article of commerce the active ingredient is released from the elastomer particles over a prolonged period of time. The active ingredients would include flavorants, intense sweeteners, colorants, medicaments, effervescent agents and tobacco.

Abstract: The invention is a liquid food for supplying protein principally containing protein, seasonings, flavoring materials and water, wherein it contains 5 to 15% by weight of lactalbumin as the protein. The lactalbumin is obtained by heating to denature under conditions so as to form a cloudy solution. The food is useful for undernourished patients who suffer from hypoproteinemia, hypoalbuminemia or common healthy men who need protein so as to desire to supply nutritious food and develop their muscles.

Abstract: Dietary compositions, especially cow's milk-based infant formulas, are fortified with bile salt-activated lipase. Methods are provided for feeding newborn and premature infants which include administration of bile salt-activated lipase to increase fat digestion and therefore growth rate. Similarly, a method is provided to treat subjects for inadequate pancreatic enzyme production by administration of bile salt-activated lipase in conjunction with ingestion of fats.

Abstract: Food compositions having an added .gamma.-linolenic acid component are provided for human and animal nutrition. The supplemented foods contain an oil extracted from pips of Ribes genus fruits containing at least 4% by weight of .gamma.-linolenic acid. The oil is substantially free from waxes, odorous compounds, colorings and free fatty acids.

Abstract: A variety of different food products, prepared from lotus, arrowhead and buckbean varieties of the families Nymphaeaceae, Alismateceae and Gentianaceae, is substituted for wheat and other grains, milk, eggs, and a partial substitute for nuts.

Abstract: A variety of different food products, prepared from malanga, taro, amorphophallus and other plants of the family Araceae, are substitutes for wheat and other grains, milk, eggs, and a partial substitute for nuts.

Abstract: The present invention relates to a process for the production of liquid and powdered bifidogenic infant and dietetic foods which are reduced in their antigenicity. The process according to the invention is characterized in that to achieve bifidogenicity, sialic acid is enzymatically cleaved from the milk proteins using the enzyme neuraminidase (sialidase).Consequently in accordance to the invention it is possible to produce bifidogenic infant foods, particularly suitable for infants, premature and small for date babies, which can additionally be used in cases of intolerances against usual milk products.Furthermore the process can be used for production of dietetic food, particularly for patients suffering from intestinal allergies, other allergic diseases and patients with insufficiency of liver and kidney.

Abstract: A variety of different food products, prepared from tubers with light colored flesh varieties of the morning glory family, Convolvulacae, are substitutes for wheat and other grains, milk, eggs, and a partial substitute for nuts.

Abstract: An improved nutritionally complete formula containing a unique fiber-containing carbohydrate blend, at a relatively low concentration; a unique fat blend, at a relatively high concentration; protein; carnitine; myoinositol; vitamins and minerals, including chromium. This formula is for the dietary management of patients with glucose intolerance.

Abstract: Food-stuff, particularly based on ruminants milk, having added thereto Lacto-N-tetraose in a gastro-intestinally effective amount; and a process for its preparation.

Abstract: Water-insoluble salts are sterilized by heating them in suspension in water together with xanthum gum or carboxymethyl cellulose which is added for improving the homogeneity and stability of the salt suspension during heating. The salts are suspended in water and the gum or cellulose is added to the suspension which is heated to a temperature of from 120.degree. C. to 150.degree. C. for sterilizing it. The sterilized suspension may be utilized to improve the nutritional qualities of products and as a coagulating agent in sterilized products including milk, dietetic products and tofu and is particularly useful for aseptically packaged products.

Abstract: Whey products having reduced allergenicity are prepared by heating an aqueous solution of a whey product containing nondenatured whey proteins in an amount of from 0.5% to 5% by weight. The solution has a pH of from 5.5 to 8.5 and a free calcium content of from 6 mmol/l to 15 mmol/l and is heated to a temperature of from 90.degree. C. to 140.degree. C. for a time sufficient for obtaining a treated whey product solution having a residual allergenic .beta.-lactoglobulin content of less than 0.1% of the .beta.-lactoglobulin content of the aqueous whey product solution to be treated.

Abstract: Substitute milk fat especially as a replacement fat in infant formulations comprises 2-saturated glycerides especially 2-palmitic acid glycerides, in which the 1, 3 positions are randomly occupied substantially by different shorter chain and/or unsaturated fatty acids. These glycerides are prepared by selective rearrangement of glycerides using 1, 3-regiospecific lipase enzymes as rearrangement catalysts, preferably in acidolysis rearrangement using unsaturated acid or alkyl ester thereof.

Abstract: A stock feed containing a specific amount of galacto-oligosaccharides, the stock feed being effective in the prevention of scours/loose passage of livestocks and thus in the increase of their weight.

Abstract: Composition for treating dehydration in swine is described according to the preferred embodiment of the teachings of the present invention for adminstration in the drinking water or feed of pigs. Generally, the treatment composition is a palatable, electrolyte water-acidifier having mulitiple sources of energy that are readily consumable by most animals. Specifically, the composition includes citric acid which is very palatable and in a concentration to reduce the pH level of the water to which it is mixed in the range of at least 2.0 units. This reduction in pH helps restore the pH of the digestive tract to normal levels. The composition further includes saccharine in its most preferred form to increase palatability factors. Additionally, multiple energy sources are provided in the composition for a wide spectrum and prolonged energy reservoir and for increased palatabiltiy.

Abstract: A method for preparing high protein rice flour (HPRF) containing low manganese is disclosed wherein essential steps comprise:blending rice flour and water at a pH of 3.4 to 4.6;separating the insoluble washed rice flour;resuspending the washed rice flour and adjusting the suspension to a pH and temperature within the operable range of an alpha-amylase enzyme;treating the suspension with an alpha-amylase enzyme for a sufficient time to hydrolyze the starch to 5 to 50 DE content;adjusting the treated mixture to a pH of 3.4 to 4.6; and theseparating rice syrup from low manganese high protein rice flour.The high protein rice flour contains more than 16% protein, has a manganese content of 50 micrograms or less per gram of protein and is further treated with a proteolytic enzyme to provide a modified low manganese HPRF suitable for use in powdered infant formula.